Note 5 - Composition of Certain Financial Statement Captions (Tables)

3 Months Ended

Mar. 31, 2025

Notes Tables

Condensed Balance Sheet [Table Text Block]

	March 31,			December 31,
(In thousands)	2025			2024
Accounts receivable, net:
Accounts receivable	$	97,684		$	119,284
Less: allowance for credit losses		(1,534	)		(1,267	)
	$	96,150		$	118,017
Inventories, net:
Consumable supplies	$	15,079		$	15,488
Finished products		39,875			32,310
Work in-process		1,589			2,355
Raw materials		10,944			9,418
Less: inventory reserve		(3,486	)		(2,774	)
	$	64,001		$	56,797
Other current assets and prepaid expenses:
Escrow receivable	$	24,193		$	23,750
Taxes recoverable		6,748			8,266
Prepaid expenses		9,494			6,785
Prepaid insurance		1,533			3,818
Other receivables		1,627			2,015
Other		10,846			10,705
	$	54,441		$	55,339
Intangible assets, net:
Customer relationships	$	203,611		$	255,430
Technologies		800,304			806,858
Trade names		49,743			49,726
Covenants not to compete		12,912			12,906
Licenses		6,371			6,316
Product registrations		6,464			6,172
Other		5,910			5,729
Less: accumulated amortization		(516,797	)		(526,524	)
	$	568,518		$	616,613
Accrued expenses:
Employee benefits and severance	$	39,948		$	34,167
Clinical trials		4,175			6,104
Commitments and contingencies		6,411			9,850
Accrued interest		5,460			8,313
Gross to net provision		5,081			6,920
Inventory received but not invoiced		1,891			2,146
Finance leases short-term		1,617			1,679
Professional fees		2,165			2,521
Taxes payable		25,714			22,275
Royalties		233			563
Commissions		1,407			1,434
Other		19,107			22,385
	$	113,209		$	118,357
Other long-term liabilities:
Employee severance	$	11,919		$	14,269
Mortgages and other debts payable		2,833			3,002
Finance leases long-term		3,799			4,064
Other		11,460			11,503
	$	30,011		$	32,838

Schedule of Goodwill [Table Text Block]

	2025
(In thousands)	Gross goodwill at January 1, 2025		Cumulative impairment at January 1			Acquisitions, dispositions and other			Foreign exchange and other			Balance at March 31, 2025
Pharmaceuticals
CURNA	$	4,827	$	(4,827	)	$	—		$	—		$	—
Rayaldee		79,433		—			—			3,232			82,665
FineTech		11,698		(11,698	)		—			—			—
ModeX		80,260		—			—			—			80,260
OPKO Biologics		139,784		—			—			(0	)		139,784
OPKO Chile		3,220		—			—			167			3,387
OPKO Health Europe		6,848		—			—			286			7,134
OPKO Mexico		100		(100	)		—			—			—
Transition Therapeutics		3,421		(3,421	)		—			—			—
Diagnostics
BioReference		219,707		—			(56,265	)		—			163,442
OPKO Diagnostics		17,977		(17,977	)		—			—			—
	$	567,275	$	(38,023	)	$	(56,265	)	$	3,685		$	476,672